Control of human T cell proliferation by platelet-activating factor
- 1 January 1990
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 12 (2) , 175-184
- https://doi.org/10.1016/0192-0561(90)90051-n
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Role of Lipoxygenase Metabolites of Arachidonic Acid in T Cell ActivationAnnals of the New York Academy of Sciences, 1988
- Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferationBiochemical and Biophysical Research Communications, 1987
- Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether]: Reversal by a specific antagonist, BN 52021Biochemical and Biophysical Research Communications, 1987
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- Effects of prostaglandin E2 and preincubation on lectin-stimulated proliferation of human T cell subsetsCellular Immunology, 1982
- Biosynthesis of platelet-activating factor (PAF-acether) II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit plateletsThrombosis Research, 1982
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- Platelet-activating factorNature, 1980
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.The Journal of Experimental Medicine, 1977
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972